CurcuVIVA™

AOR04257

Highly Absorbable and Rffective Curcumin Formula

  • Allows slow breakdown by the body
  • Mild dose-optimized curcumin from turmeric
  • Remains in the bloodstream for up to 24 hours
Gluten Free
Non-GMO
Vegan

$52.45 $47.21 subscription plans starting at $52.45 $44.58 / month

In stock

Choose a subscription plan:

CurcuVIVA™ provides an 80 mg maintenance dose of Longvida Optimized Curcumin for those with osteoarthritis, joint pain, chronic pain and more. Longvida Curcumin was specially formulated to provide a solution to the curcumin conundrum of low bioavailability, poor absorption and rapid breakdown. Although bioavailability and absorption help determine effectiveness, the key lies within its ability to remain free. This free state of curcumin is achieved due to the formula’s ability to avoid being rapidly broken down within the body. Because free curcumin retains its “unbroken” form, it is then taken up through the lymph system into the bloodstream where it is stable, concentrated, and retains maximum effectiveness for up to 24 hours.

Curcumin not only provides relief from joint pain and arthritis, but has many other benefits. It supports digestion, liver and gallbladder health, carries antibacterial, antifungal and antiviral effects, and even promotes healthy cholesterol levels and cardiovascular health.

NPN

80034713

Discussion

CurcuVIVA™ contains Longvida®, a highly effective curcumin formula that supports joint health.*

Guarantees

AOR™ guarantees that all ingredients have been declared on the label. Made without wheat, gluten, nuts, peanuts, dairy, eggs, fish, shellfish or any animal by-product.

AOR Advantage

Longvida® curcumin was introduced to Canada exclusively by AOR in 2011. CurcuVIVA’s advanced technology allows it to be absorbed very rapidly by the body, meaning that it is an excellent choice for rapid pain relief. Furthermore, with an effective dose of just one capsule per day CurcuVIVA is more convenient and more economical than most other curcumin supplements out there!

AOR’s CurcuVIVATM is based on this proven technology and has the following advantages:

Clinically tested with results published in 2010 in the prestigious Journal of Agricultural and Food Chemistry. In the study, patients with cancer of the bone experienced few to no adverse effects and good tolerability of the equivalent of up to 15 capsules of CurcuVIVA.

A 100-fold increase in bioavailability compared to regular curcumin

Patented by the University of California

Published study showing positive effects in reducing beta-amyloid levels in humans at 80 mg in just one month

CurcuVIVA TM consists of solid lipid particles (SLP) which are tiny nano-sized (1 billionth of a meter) particles that have a protected layer that provides a phenomenal increase in stability, potency and effectiveness. Unlike regular curcumin that is easily broken down by stomach acids, Curcumin Fast Relief particles are resistant to acid breakdown. Even more important is the fact that these tiny particles are absorbed very rapidly. This means that they deliver all of the health benefits of curcumin, including pain relief, reduced inflammation, antioxidant properties and other effects much faster than any other curcumin product.

Try CurcuVIVA TM today and start feeling the benefits of a real high-potency, high-bioavailability curcumin supplement.

Adult Dosage

Take 1 capsule per day with/without food, or as directed by a qualified health care practitioner.

Cautions

Consult your health care practitioner prior to use if you are pregnant, lactating, or taking any medication ( e.g. antiplatelet medications or blood thinners), or have a medical condition ( e.g. have stomach ulcers, excess stomach acid, gallstones, or a bile duct obstruction). Keep out of reach of children.

Main Applications
  • Antioxidant
  • Immune health support
  • Cognitive support
  • Cellular growth and differentiation
  • Lipid metabolism
  • Gastrointestinal health
Disclaimer

The information and product descriptions appearing on this website are for information purposes only, and are not intended to provide or replace medical advice to individuals from a qualified health care professional. Consult with your physician if you have any health concerns, and before initiating any new diet, exercise, supplement, or other lifestyle changes.

Serving Size: 1 Capsule
Amount Per Serving
% Daily Value
Curcumin Extract
(Curcuma longa (Turmeric) [Rhizome]) min. 23% Curcuminoids
400 mg

†Daily Value not established

Non-medical Ingredients: capsule (hypromellose, glycerin and water), soy lecithin, organic rice hulls, stearic acid, maltodextrin, ascorbyl palmitate, silicon dioxide.

Contains: Soy.

Curcumin is currently being heavily studied for use as an adjunct to conventional cancer treatments. Unfortunately, most of the studies have noted minimal results despite promising in vitro and animal studies. Researchers have recognized that the cause for the poor results is curcumin’s poor bioavailability.

Bioavailability

Gota and colleagues did a safety and bioavailability study on healthy volunteers and patients with non-responsive bone cancer. Subjects were given doses between 400 and 1,200 mg of curcumin in solid lipid particle form (equivalent to 1 to 3 capsules of CurcuVIVA). All doses showed significant absorption into the bloodstream over 8 hours with no adverse events. This is especially significant since previous studies giving 8,000-12,000 mg of pure regular curcumin barely showed any blood levels or clinical improvements.  In addition, the 1,200 mg dose produced blood levels of curcumin necessary to reduce isoprostanes, TNF-α, and amyloid-β, which are markers for diseases like cancer and Alzheimer’s disease.

Amyloid-β Reductions

There is also significant interest in its ability to reduce amyloid-β plaque, which is thought to be a causative factor of Alzheimer’s disease. In vitro and animal studies have shown that curcumin can significantly reduce levels of amyloid-β and preserve Alzheimer model animal memory. Finally, a recent human study has shown that just 80 mg of curcumin can reduce amyloid-β in humans. The curcumin that was finally able to do so was Longvida® curcumin SLP, and in just one month.

Longvida® Curcumin in Humans

A human trial on curcumin showed statistically significant effects on clinical endpoints in a healthy population. The fact that such a low dose (80 mg) was needed to achieve effects in only 30 days is an interesting and unique finding as well, and adds to the substantial amount of pharmacokinetic and pharmacodynamic data compiled on Longvida®. The results of the study suggest that curcumin can produce beneficial effects in people who are without immediate disease states. The study was conducted on 38 healthy middle aged people between the age of 40 and 60 who were either given a dose of 80 mg/day of Longvida® curcumin extract for four weeks or were a part of the 19 person placebo group. The study is particularly interesting because the relatively small dose of curcumin, from Longvida® which was used, exerted a variety of health promoting effects leading researchers to presume that a significant amount of the curcumin was absorbed, although not tested directly.

Blood sample readings collected from test subjects to assess nitric oxide and sICAM molecules which are relevant to assessing cardiovascular risk and related to blood pressure and atherosclerosis, were notably affected by the curcumin. Both readings corresponded to a decreased risk of cardiovascular disease. The study also indicated that curcumin may have a positive effect on liver health maintenance as was noted from the reduction of indicators used to mark liver injury. Participants had lowered levels of triglycerides which relates to other research demonstrating that cholesterol could potentially be lowered in relatively healthy persons given higher dosages of the substance, thus benefiting those with or at risk of having cardiovascular disease.

Interestingly, other markers of inflammation and free radicals/toxic species that cause inflammation and damage to cells were also significantly lowered. Both direct and indirect antioxidant actions of curcumin were evident in the subjects; these findings are consistent with in vitro and animal studies used to measure increases in curcumin induced antioxidant enzyme activity.

Please select a start rating
{{review.user_complete_name}}
{{review.date | date:'medium'}}
{{review.comment}}
Comment pending for approval
Reply
{{child.user_complete_name}}
{{child.date | date:'medium'}}
{{child.comment}}
Comment pending for approval
Reply
{{child2.user_complete_name}}
{{child2.date | date:'medium'}}
{{child2.comment}}
Comment pending for approval
Reply